Insud Pharma
Aitor Alférez Plaza has a diverse work experience in the pharmaceutical industry. Aitor started their career at Laboratorios Rubió in 2014 as an Rx Business Development Manager, where they were responsible for seeking and managing new licensing-in opportunities and establishing partnerships. Aitor also attended pharmaceutical fairs and conferences to identify potential projects of high interest and potential. In 2017, they joined Italfarmaco as a Business Development Manager, focusing on in-licensing projects in various therapeutic fields such as CNS, Rheumatology, Dermatology, Women's Health, Respiratory, and Primary Care. Aitor conducted benchmark analyses and actively searched for prescription drugs, medical devices, and food supplements with scientific support to offer new alternatives to physicians. Aitor then joined Adalvo in 2021 as a Director of Business Development, where they continued to showcase their skills in identifying business opportunities and product specialization. Aitor later assumed the role of Senior Director of Business Development and Product Specialist until 2022. Currently, Aitor works at Insud Pharma as the Director of Portfolio & Alliance Management.
Aitor Alférez Plaza pursued a Licentiate degree in Pharmacy at Universidad de Granada from 2007 to 2012. Following that, they obtained a Master's degree in Research, Development and Control of drugs from Universitat de Barcelona in 2013 and 2014. Aitor later completed an Executive programme in Business Development and Licensing at CESIF in 2017. In 2021, Aitor attended CESIF again for an Executive programme in Market access.
This person is not in any offices
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.